Drug Repurposing for Terminal-Stage Cancer Patients
Language English Country United States Media print
Document type Letter, Comment
PubMed
27153031
PubMed Central
PMC4880249
DOI
10.2105/ajph.2016.303129
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Neoplasms * MeSH
- Drug Discovery MeSH
- Drug Repositioning * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
See more in PubMed
Aldridge MD, Kelley AS. The myth regarding the high cost of end-of-life care. Am J Public Health. 2015;105(12):2411–2415. PubMed PMC
Drugs on demand. Nature. 2015;527(7579):410. PubMed
Nechushtan H, Hamamreh Y, Nidal S et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist. 2015;20(4):366–367. PubMed PMC
Cvek B. Nonprofit drugs as the salvation of the world’s healthcare systems: the case of Antabuse (disulfiram) Drug Discov Today. 2012;17(9–10):409–412. PubMed
